Response to Houlihan et al

To the Editor: We apologize for the oversight and resultant errors in Table 5 in our paper “Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis” (1). In the actual text of the article, the reference to the table does correctly state that “Comparable rates of 20–25% early mortality have been reported in other studies (12, 13, 14, 18) ( Table 5)” ((2,3,4,5)). However, the 30-day mortality column in Table 5 has errors as noted by Parker et al. (6). We have corrected the numbers and attached a new version below. One of the studies in the original Table 5 by Siegerstetter et al. (7) only reported 6-month mortality (15%) and not 30-day mortality, so we removed it from the corrected table.